miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression

MLA

Jinyi Zhong, et al. “MiR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression.” Journal of Cancer, vol. 10, no. 12, June 2019, pp. 2745–53. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1d8bdb936065ded5591cc3351dc7060&authtype=sso&custid=ns315887.

APA

Jinyi Zhong, Wenxin Li, Wenda Li, Xianqing Chen, Changzhen Shang, Sicong Zhu, Yajin Chen, & Wenliang Tan. (2019). miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression. Journal of Cancer, 10(12), 2745–2753.

Chicago

Jinyi Zhong, Wenxin Li, Wenda Li, Xianqing Chen, Changzhen Shang, Sicong Zhu, Yajin Chen, and Wenliang Tan. 2019. “MiR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression.” Journal of Cancer 10 (12): 2745–53. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1d8bdb936065ded5591cc3351dc7060&authtype=sso&custid=ns315887.